EUVIMEDEUVIMED entdecken
Open Access

Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment

Wenyan She iD, Xiaojuan Jiang iD, Siying Deng, Luyuan Hu, Chenxi Huang, Lin Hou iD

Science Advances · 2026

DOI: 10.1126/sciadv.aed0407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Wenyan She und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Nanoparticles, Insulin-Secreting Cells, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, Program for Innovative Research Team (in Science and Technology) in University of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus remains a global health challenge, as current insulin-based therapies merely control blood glucose without restoring islet β cell function, leaving patients dependent on lifelong medication and vulnerable to hypoglycemia. Antioxidant drugs hold promise for islet β cell repair but are limited by poor gastrointestinal transportation and insufficient pancreatic targetability. Here, we initially identify ferroptosis-associated oxidative stress as a key cause of islet β cell death and develop six stiffness-gradient nanoparticles by embedding bent oleic acid into ordered 1,2-distearoyl- sn -glycero-3-phosphoethanolamine to enhance drug bioavailability. Nanoparticles with intermediate stiffness optimize membrane wrapping and minimize energetic cost, enhancing intestinal M cell transcytosis and macrophage-mediated hitchhiking, thereby increasing pancreatic curcumin accumulation by ~4.5-fold. In diabetic models, this formulation suppresses ferroptosis-associated oxidative stress, promotes in situ islet β cell repair, and restores insulin homeostasis and autonomous glycemic control, maintaining normoglycemia without hypoglycemia even after treatment cessation. This study represents a patient-friendly oral nanotherapy that outperforms insulin therapy in long-standing diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesInsulin-Secreting CellsDiabetes Mellitus, ExperimentalAnimalsOxidative StressAdministration, OralInsulinHumansMiceCurcuminHypoglycemic Agents

Substanzen

InsulinCurcuminHypoglycemic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou University, Zhengzhou 450001, China.
  • State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.

ORCID-Profile: Wenyan She, Xiaojuan Jiang, Lin Hou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Henan Province
  • Program for Innovative Research Team (in Science and Technology) in University of Henan Province
  • Science and Technology R&D Plan Joint Fund of Henan Province
  • Zhongyuan Sci-Tech Innovation Leading Talents
  • Postdoctoral Fellowship Program (Grade B) of China Postdoctoral Science Foundation

Zitieren

APA

She, W., Jiang, X., Deng, S., Hu, L., Huang, C., & Hou, L. (2026). Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment. Science Advances. https://doi.org/10.1126/sciadv.aed0407

Vancouver

She W, Jiang X, Deng S, Hu L, Huang C, Hou L. Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment. Science Advances. 2026. doi:10.1126/sciadv.aed0407

BibTeX
@article{She2026,
  author = {She, Wenyan and Jiang, Xiaojuan and Deng, Siying and Hu, Luyuan and Huang, Chenxi and Hou, Lin},
  title = {Stiffness-tunable oral nanoparticles facilitate damaged islet β cell restoration for diabetes treatment},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aed0407}
}
Kostenlos starten →